1-6 of 6
Paola Neri
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Immunomodulation in Pomalidomide, Dexamethasone, and Daratumumab-Treated Patients with Relapsed/Refractory Multiple Myeloma

William E. Pierceall, Michael D. Amatangelo, Nizar J. Bahlis, David S. Siegel, Adeeb Rahman, Oliver Van Oekelen, Paola Neri, Mary Young, Weiyuan Chung, Natalya Serbina, Samir Parekh, Amit Agarwal, Anjan Thakurta
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2020) 26 (22): 5895–5902.
https://doi.org/10.1158/1078-0432.CCR-20-1781
Published: 13 November 2020
View article titled, Immunomodulation in Pomalidomide, Dexamethasone, and Daratumumab-Treated Patients with Relapsed/Refractory Multiple Myeloma
Open the PDF for Immunomodulation in Pomalidomide, Dexamethasone, and Daratumumab-Treated Patients with Relapsed/Refractory Multiple Myeloma in another window
Includes: Supplementary data
Journal Articles

New Strategies in Multiple Myeloma: Immunotherapy as a Novel Approach to Treat Patients with Multiple Myeloma

Paola Neri, Nizar J. Bahlis, Sagar Lonial
Journal: Clinical Cancer Research
Clin Cancer Res (2016) 22 (24): 5959–5965.
https://doi.org/10.1158/1078-0432.CCR-16-0184
Published: 15 December 2016
View article titled, New Strategies in Multiple Myeloma: Immunotherapy as a Novel Approach to Treat Patients with Multiple Myeloma
Open the PDF for New Strategies in Multiple Myeloma: Immunotherapy as a Novel Approach to Treat Patients with Multiple Myeloma in another window
Journal Articles

Reovirus as a Viable Therapeutic Option for the Treatment of Multiple Myeloma

Chandini M. Thirukkumaran, Zhong Qiao Shi, Joanne Luider, Karen Kopciuk, He Gao, Nizar Bahlis, Paola Neri, Mark Pho, Douglas Stewart, Adnan Mansoor, Don G. Morris
Journal: Clinical Cancer Research
Clin Cancer Res (2012) 18 (18): 4962–4972.
https://doi.org/10.1158/1078-0432.CCR-11-3085
Published: 16 September 2012
View article titled, Reovirus as a Viable Therapeutic Option for the Treatment of Multiple Myeloma
Open the PDF for Reovirus as a Viable Therapeutic Option for the Treatment of Multiple Myeloma in another window
Includes: Supplementary data
Journal Articles

Neutralizing B-Cell–Activating Factor Antibody Improves Survival and Inhibits Osteoclastogenesis in a Severe Combined Immunodeficient Human Multiple Myeloma Model

Paola Neri, Shaji Kumar, Maria Teresa Fulciniti, Sonia Vallet, Shweta Chhetri, Sidhartha Mukherjee, YuTzu Tai, Dharminder Chauhan, Pierfrancesco Tassone, Salvatore Venuta, Nikhil C. Munshi, Teru Hideshima, Kenneth C. Anderson, Noopur Raje
Journal: Clinical Cancer Research
Clin Cancer Res (2007) 13 (19): 5903–5909.
https://doi.org/10.1158/1078-0432.CCR-07-0753
Published: 01 October 2007
View article titled, Neutralizing B-Cell–Activating Factor Antibody Improves Survival and Inhibits Osteoclastogenesis in a Severe Combined Immunodeficient Human Multiple Myeloma Model
Open the PDF for Neutralizing B-Cell–Activating Factor Antibody Improves Survival and Inhibits Osteoclastogenesis in a Severe Combined Immunodeficient Human Multiple Myeloma Model in another window
Journal Articles

MLN120B, a Novel IκB Kinase β Inhibitor, Blocks Multiple Myeloma Cell Growth In vitro and In vivo

Teru Hideshima, Paola Neri, Pierfranchesco Tassone, Hiroshi Yasui, Kenji Ishitsuka, Noopur Raje, Dharminder Chauhan, Klaus Podar, Constantine Mitsiades, Lenny Dang, Nikhil Munshi, Paul Richardson, David Schenkein, Kenneth C. Anderson
Journal: Clinical Cancer Research
Clin Cancer Res (2006) 12 (19): 5887–5894.
https://doi.org/10.1158/1078-0432.CCR-05-2501
Published: 04 October 2006
View article titled, MLN120B, a Novel IκB Kinase β Inhibitor, Blocks Multiple Myeloma Cell Growth <em>In vitro</em> and <em>In vivo</em>
Open the PDF for MLN120B, a Novel IκB Kinase β Inhibitor, Blocks Multiple Myeloma Cell Growth <em>In vitro</em> and <em>In vivo</em> in another window
Journal Articles

Combination Therapy with Interleukin-6 Receptor Superantagonist Sant7 and Dexamethasone Induces Antitumor Effects in a Novel SCID-hu In vivo Model of Human Multiple Myeloma

Pierfrancesco Tassone, Paola Neri, Renate Burger, Rocco Savino, Masood Shammas, Laurence Catley, Klaus Podar, Dharminder Chauhan, Serena Masciari, Antonella Gozzini, Pierosandro Tagliaferri, Salvatore Venuta, Nikhil C. Munshi, Kenneth C. Anderson
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (11): 4251–4258.
https://doi.org/10.1158/1078-0432.CCR-04-2611
Published: 01 June 2005
View article titled, Combination Therapy with Interleukin-6 Receptor Superantagonist Sant7 and Dexamethasone Induces Antitumor Effects in a Novel SCID-hu <em>In vivo</em> Model of Human Multiple Myeloma
Open the PDF for Combination Therapy with Interleukin-6 Receptor Superantagonist Sant7 and Dexamethasone Induces Antitumor Effects in a Novel SCID-hu <em>In vivo</em> Model of Human Multiple Myeloma in another window